ICAM1 and endothelial dysfunction: Wilson et al. showed the effects of tirzepatide on the levels of inflammatory markers YKL-40 and hsCRP; a marker of endothelial dysfunction, ICAM-1; and leptin, a satiety hormone secreted by adipose tissue [33].